Pharmacopeia (PCOP) Surges On Positive DARA Phase 2a Trial Data
Tweet Send to a Friend
Shares of Pharmacopeia (Nasdaq: PCOP) are 33% higher in pre-open trading today after the company announced that PS433540, its first-in-class ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


